You are here: Home » News-CM » Companies » Results
Business Standard

Claris Lifesciences reports consolidated net profit of Rs 36.96 crore in the March 2017 quarter

Capital Market 

Sales decline 75.82% to Rs 4.41 crore

Net profit of Claris Lifesciences reported to Rs 36.96 crore in the quarter ended March 2017 as against net loss of Rs 0.62 crore during the previous quarter ended March 2016. Sales declined 75.82% to Rs 4.41 crore in the quarter ended March 2017 as against Rs 18.24 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 109.93 crore in the year ended March 2017 as against net loss of Rs 39.44 crore during the previous year ended March 2016. Sales declined 80.83% to Rs 25.53 crore in the year ended March 2017 as against Rs 133.16 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales4.4118.24 -76 25.53133.16 -81 OPM %-390.48-113.87 --349.43-127.73 - PBDT33.61-5.71 LP 94.34-58.49 LP PBT32.00-6.78 LP 90.37-62.35 LP NP36.96-0.62 LP 109.93-39.44 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Claris Lifesciences reports consolidated net profit of Rs 36.96 crore in the March 2017 quarter

Sales decline 75.82% to Rs 4.41 crore

Sales decline 75.82% to Rs 4.41 crore

Net profit of Claris Lifesciences reported to Rs 36.96 crore in the quarter ended March 2017 as against net loss of Rs 0.62 crore during the previous quarter ended March 2016. Sales declined 75.82% to Rs 4.41 crore in the quarter ended March 2017 as against Rs 18.24 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 109.93 crore in the year ended March 2017 as against net loss of Rs 39.44 crore during the previous year ended March 2016. Sales declined 80.83% to Rs 25.53 crore in the year ended March 2017 as against Rs 133.16 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales4.4118.24 -76 25.53133.16 -81 OPM %-390.48-113.87 --349.43-127.73 - PBDT33.61-5.71 LP 94.34-58.49 LP PBT32.00-6.78 LP 90.37-62.35 LP NP36.96-0.62 LP 109.93-39.44 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Claris Lifesciences reports consolidated net profit of Rs 36.96 crore in the March 2017 quarter

Sales decline 75.82% to Rs 4.41 crore

Net profit of Claris Lifesciences reported to Rs 36.96 crore in the quarter ended March 2017 as against net loss of Rs 0.62 crore during the previous quarter ended March 2016. Sales declined 75.82% to Rs 4.41 crore in the quarter ended March 2017 as against Rs 18.24 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 109.93 crore in the year ended March 2017 as against net loss of Rs 39.44 crore during the previous year ended March 2016. Sales declined 80.83% to Rs 25.53 crore in the year ended March 2017 as against Rs 133.16 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales4.4118.24 -76 25.53133.16 -81 OPM %-390.48-113.87 --349.43-127.73 - PBDT33.61-5.71 LP 94.34-58.49 LP PBT32.00-6.78 LP 90.37-62.35 LP NP36.96-0.62 LP 109.93-39.44 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22